stockportfolio.pro
Eli Lilly and Company Total Debt 2008–2025
Eli Lilly and Company (LLY) annual total debt (short- plus long-term borrowings) by fiscal year, computed from SEC filings. Compound growth +8.6%/yr over 17 years.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $42.50B | +22.9% |
| FY 2024 | $34.59B | +33.0% |
| FY 2023 | $26.01B | +59.4% |
| FY 2022 | $16.32B | -10.7% |
| FY 2021 | $18.28B | +11.8% |
| FY 2020 | $16.36B | +8.1% |
| FY 2019 | $15.14B | +47.0% |
| FY 2018 | $10.30B | -24.5% |
| FY 2017 | $13.65B | +24.7% |
| FY 2016 | $10.94B | +37.1% |
| FY 2015 | $7.98B | -0.5% |
| FY 2014 | $8.02B | +28.8% |
| FY 2013 | $6.23B | +12.3% |
| FY 2012 | $5.54B | -34.8% |
| FY 2011 | $8.50B | +22.5% |
| FY 2010 | $6.94B | +3.9% |
| FY 2009 | $6.68B | -36.1% |
| FY 2008 | $10.46B | — |
Source: Eli Lilly and Company SEC filings — balance sheet (10-K). Refreshed nightly.
See the full picture for Eli Lilly and Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeEli Lilly and Company — frequently asked questions
What is Eli Lilly and Company's total debt (short- plus long-term borrowings)?
Eli Lilly and Company (LLY) reported total debt (short- plus long-term borrowings) of $42.50B for fiscal year 2025, per its SEC filings.
How has Eli Lilly and Company's total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2008 and 2025, LLY's total debt (short- plus long-term borrowings) grew at roughly 8.6% per year (compound annual rate), from $10.46B to $42.50B.
Where does this data come from?
Figures are computed from Eli Lilly and Company's official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.